11 výsledky
The present invention relates to galactosylated pro-drugs of non-steroidal anti-inflammatories with free acid function and the process of synthesis thereof, which enables minimization of the gastrointestinal toxicity of the starting anti-inflammatory by means of esterification of its carboxylic
BACKGROUND
Inflammatory diseases such as psoriasis, dermatitis, acne, rosacea, photo-dermal ageing, and numerous diseases linked to RAGE-mediated signaling plague people worldwide. To put these diseases into perspective, the National Psoriasis Foundation reports that psoriasis alone afflicts 2-3% of
This application is a U.S. national stage of PCT/EP2017/066002 filed on 28 Jun. 2017, which claims priority to and the benefit of Italian Application No. 102016000067621 filed on 29 Jun. 2016, the contents of which are incorporated herein by reference in their entireties.
TECHNICAL FIELD OF
FIELD OF THE INVENTION
This invention relates to novel compositions and novel methods of treating inflammatory bowel disease (IBD). More particularly, this invention pertains to novel compositions containing N-acetyl-glucosamine (NAG) as an active IBD treating agent and a pharmacologically and
CROSS REFERENCE TO RELATED APPLICATION
This is a National Stage of International Application PCT/EP2007/006666, filed 27 Jul. 2007, which claims the benefit of Application No. 06016518.0, filed in Europe on 8 Aug. 2006, the disclosures of which Applications are incorporated by reference
This application is the U.S. national stage entry under 35 U.S.C. .sctn. 371 of international application PCT/US95/16722, filed Dec. 11, 1995.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to a unique combination of nutritional supplements and a method. More
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is directed to a unique combination of nutritional supplements and a method. More specifically, this invention is directed to a unique combination of nutritional supplements which provides symptomatic relief from arthritis. The
FIELD OF THE INVENTION
The present invention is a beverage used to treat an inflammatory tissue or arthritic condition in a mammal involving tissue that is underperfused tissue, inflamed joints, or inflamed muscles. The present invention is also a beverage additive in which those who suffer from
FIELD OF INVENTION
The current invention is within the pharmaceutical field, specifically for treatment of joint disorders such as rheumatoid arthritis and osteoarthritis.
TECHNICAL BACKGROUND
Chitin and chitosan are biopolymers, which typically are obtained from crustacean shell wastes, but can
FIELD OF INVENTION
The current invention is within the pharmaceutical field, specifically for treatment of joint disorders such as rheumatoid arthritis and osteoarthritis.
TECHNICAL BACKGROUND
Chitin and chitosan are biopolymers, which typically are obtained from crustacean shell wastes, but can
FIELD OF THE INVENTION
The present invention is a beverage used to treat an inflammatory tissue or arthritic condition in a mammal involving tissue that is underperfused tissue, inflamed joints, or inflamed muscles. The present invention is also a beverage additive in which those who suffer from